Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04572633 · ClinicalTrials.gov registry record · NA
The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy
A NA study of Hepatocellular Carcinoma and Liver Metastases, sponsored by HistoSonics.
- Active
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 7
- Study locations
NCT04572633 is a NA study of Hepatocellular Carcinoma and Liver Metastases that is active but no longer recruiting, run by HistoSonics. The registered enrollment target is 47 participants, below the 257-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (82% lower). The trial reports 7 study locations across 5 states.
The verdict
NCT04572633, a NA study of Hepatocellular Carcinoma and Liver Metastases, is active but no longer recruiting, sponsored by HistoSonics.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 7
- Study locations
Study Summary
This trial is a single arm, non-randomized prospective trial. The objective of this trial is to evaluate the efficacy and safety of the HistoSonics System for the treatment of primary or metastatic tumors located in the liver. The co-primary safety and efficacy endpoints must be met for the trial to be successful.
Conditions Studied
Interventions
- DEVICE HistoSonics System
Study Locations (7)
Florida
- Miami Cancer Institute - Miami
- Tampa General Hospital - Tampa
Wisconsin
- University Hospital - UW Health - Madison
- Medical College of Wisconsin/Froedtert Hospital - Milwaukee
Illinois
- University of Chicago - Chicago
Kansas
- University of Kansas Medical Center - Kansas City
Michigan
- University of Michigan Hospital - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2021-01-27 |
| Est. Completion | 2027-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04572633
The ClinicalTrials.gov registry entry for NCT04572633 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 257-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (82% lower). The listed sponsor is HistoSonics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Hepatocellular Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which HistoSonics System is the first listed.
NCT04572633 reports 7 study locations spanning 5 distinct geographic areas - top geographies include Florida, Wisconsin, Illinois.
Frequently Asked Questions
What is clinical trial NCT04572633 about?
NCT04572633 is a clinical study titled "The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy". This trial is a single arm, non-randomized prospective trial. The objective of this trial is to evaluate the efficacy and safety of the HistoSonics System for the treatment of primary or metastatic tumors located in the liver. The co-primary safety and efficacy endpoints must be met for the trial to...
What is the current status of trial NCT04572633?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 47 participants. The study started on 2021-01-27. Estimated completion is 2027-09.
What conditions does trial NCT04572633 study?
This clinical trial studies the following conditions: Hepatocellular Carcinoma, Liver Metastases, Liver Neoplasms.
What interventions are being tested in trial NCT04572633?
The interventions under investigation include: HistoSonics System (DEVICE).
Who is sponsoring clinical trial NCT04572633?
This trial is sponsored by HistoSonics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04572633 being conducted?
This trial has 7 study locations across Florida, Illinois, Kansas, Michigan, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatocellular Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Targeted Navigation in Hepatocellular Carcinoma (HCC)
RECRUITING · NA
-
Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment
RECRUITING · NA
-
HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
RECRUITING · NA
-
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
RECRUITING · NA
-
Psychoeducational Intervention for Patients With Hepatocellular Carcinoma
RECRUITING · NA
-
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.